Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of CADI-05 in Patients With Advanced Stage Melanoma
This study has been terminated.
( DSMB reviewed data of 1st 10 subjects; determined no safety concerns. Efficacy as a single agent in this patient population was unlikely. Voluntary Termination )
Study NCT00675727   Information provided by Cadila Pharnmaceuticals

First Received on May 8, 2008.   Last Updated on June 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial